Department of Neurology, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0525, USA.
Stroke. 2011 Nov;42(11):3122-6. doi: 10.1161/STROKEAHA.110.612937. Epub 2011 Sep 15.
Previously in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort, we found 18% of the stroke/transient ischemic attack-free study population reported ≥1 stroke symptom at baseline. We sought to evaluate the additional impact of these stroke symptoms on risk for subsequent stroke.
REGARDS recruited 30,239 US blacks and whites, aged 45+ years in 2003 to 2007 who are being followed every 6 months for events. All stroke events are physician-verified; those with prior diagnosed stroke or transient ischemic attack are excluded from this analysis. At baseline, participants were asked 6 questions regarding stroke symptoms. Measured stroke risk factors were components of the Framingham Stroke Risk Score.
After excluding those with prior stroke or missing data, there were 24,412 participants in this analysis with a median follow-up of 4.4 years. Participants were 39% black, 55% female, and had median age of 64 years. There were 381 physician-verified stroke events. The Framingham Stroke Risk Score explained 72.0% of stroke risk; individual components explained between 0.2% (left ventricular hypertrophy) and 5.7% (age+race) of stroke risk. After adjustment for Framingham Stroke Risk Score factors, stroke symptoms were significantly related to stroke risk: for each stroke symptom reported, the risk of stroke increased by 21% per symptom.
Among participants without self-reported stroke or transient ischemic attack, prior stroke symptoms are highly predictive of future stroke events. Compared with Framingham Stroke Risk Score factors, the impact of stroke symptom on the prediction of future stroke was almost as large as the impact of smoking and hypertension and larger than the impact of diabetes and heart disease.
先前在 REasons for Geographic And Racial Differences in Stroke(REGARDS)队列研究中,我们发现基线时有 18%的无卒中和短暂性脑缺血发作(TIA)研究人群报告有≥1 个卒中风症状。我们试图评估这些卒中风症状对后续卒中风险的额外影响。
REGARDS 于 2003 年至 2007 年招募了 30239 名年龄在 45 岁以上的美国黑人和白人,每 6 个月随访一次事件。所有卒中事件均由医生核实;既往诊断为卒中或 TIA 的患者被排除在本分析之外。在基线时,参与者被问及 6 个有关卒中症状的问题。测量的卒中危险因素是Framingham 卒中风险评分的组成部分。
排除既往卒中或缺失数据后,本分析有 24412 名参与者,中位随访时间为 4.4 年。参与者 39%为黑人,55%为女性,中位年龄为 64 岁。有 381 例经医生核实的卒中事件。Framingham 卒中风险评分解释了 72.0%的卒中风险;各组成部分分别解释了 0.2%(左心室肥厚)至 5.7%(年龄+种族)的卒中风险。调整 Framingham 卒中风险评分因素后,卒中症状与卒中风险显著相关:每报告一个卒中症状,卒中风险增加 21%。
在无自我报告的卒中或 TIA 的参与者中,既往卒中症状高度预测未来的卒中事件。与 Framingham 卒中风险评分因素相比,卒中症状对未来卒中的预测影响几乎与吸烟和高血压的影响一样大,大于糖尿病和心脏病的影响。